CAPTRUST Financial Advisors
BMY.RT

CAPTRUST Financial Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,293
Closed -$10K – 4614
2020
Q4 		$10K Sell
14,293
-23,876
-63% -$50.9K ﹤0.01% 2591
2020
Q3 		$100K Buy
38,169
+19,968
+110% +$57K ﹤0.01% 1340
2020
Q2 		$61K Sell
18,201
-32,621
-64% -$118K ﹤0.01% 1551
2020
Q1 		$192K Buy
50,822
+37,942
+295% +$125K ﹤0.01% 867
2019
Q4 		$39K Buy
+12,880
New +$33.5K ﹤0.01% 1005

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

CAPTRUST Financial Advisors's BMY.RT Position: Q1 2021 in Review

CAPTRUST Financial Advisors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 14,293 shares — an estimated $10K sold.

CAPTRUST Financial Advisors first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $192K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • CAPTRUST Financial Advisors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 14,293 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $10K.
  • CAPTRUST Financial Advisors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • CAPTRUST Financial Advisors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $192K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2021, filed 17 May 2021.